Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology reports developments in digital orthodontics and restorative dentistry through its Invisalign System of clear aligners, iTero intraoral scanners, exocad CAD/CAM software and the Align Digital Platform. Company news commonly covers product and workflow updates for clear-aligner treatment planning, intraoral scanning, 3D visualization and digitally connected dental practices.
Recurring updates also include quarterly and annual operating results, clear-aligner shipment and channel trends, regional demand, foreign-exchange effects, stock repurchase activity, financial-conference participation and governance or shareholder-voting matters. Other announcements describe clinical education, professional collaborations and access-to-care initiatives involving orthodontists, general practitioner dentists and dental research organizations.
Align Technology (Nasdaq: ALGN) has announced it will report its third quarter 2024 financial results on Wednesday, October 23, 2024, after market close. The results will be released at 4:00 p.m. ET and will be available on the company's Investor Relations website. A conference call to discuss the results will follow at 4:30 p.m. ET, which will also be accessible via webcast.
Align Technology is a global medical device company specializing in clear aligners, intraoral scanners, and CAD/CAM software for digital orthodontics and restorative dentistry. The company's product portfolio includes the Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software. Align has treated over 18.2 million patients with the Invisalign System and serves more than 266,000 doctor customers worldwide.
Align Technology (NASDAQ: ALGN) announced that the U.S. District Court for the Northern District of California has granted preliminary approval of a settlement to resolve shareholder derivative litigation pending since 2019. Under the settlement terms:
- Plaintiffs will dismiss lawsuits and release claims
- Align and defendants deny wrongdoing
- No monetary payments, except potential $575,000 in attorney's fees to plaintiffs' counsel, covered by insurance
The settlement includes corporate governance reforms to be maintained for at least 3 years, such as:
- Formalizing a management-level Disclosure Committee
- Adding a cybersecurity expert to the Audit Committee
- Enhancing board training and disclosures
- Expanding compliance and ethics roles
A final approval hearing is scheduled for February 4, 2025. Stockholders may object to the settlement by December 24, 2024.
Align Technology (Nasdaq: ALGN), a leading global medical device company, has announced its participation in an upcoming financial conference. The company, known for its Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software, will be presenting at Baird's 2024 Global Healthcare Conference on September 10, 2024, from 9:05 to 9:35 a.m. ET in New York, NY. John Morici, CFO, will be the speaker.
The presentation will be webcast live via Align's Investor Relations website, with an archived replay available for approximately three months. Align Technology has treated over 18.2 million patients with the Invisalign System and serves more than 266,000 doctor customers worldwide, targeting a 600 million consumer market opportunity.
Align Technology (Nasdaq: ALGN) has announced key leadership changes for its regional operations. David Carr, a medical technology industry veteran, joins as EVP and MD of the Asia Pacific region. Raj Pudipeddi, current EVP and MD of Asia Pacific and Chief Marketing Officer, will lead the Americas region while retaining his CMO role. Simon Beard continues to lead the EMEA region as EVP and MD.
These changes aim to strengthen Align's global leadership team, leveraging each executive's expertise in their respective markets. Carr brings over 25 years of management experience in healthcare and automotive industries, with a deep understanding of the Asia Pacific region. This restructuring is part of Align's strategy to enhance its position in the clear aligner and digital dentistry markets, serving over 266,000 doctors and targeting a 600 million consumer market opportunity worldwide.
Align Technology (NASDAQ: ALGN) has launched a pilot promotional program for Invisalign treatment on Costco.com in the U.S. Costco members can purchase an Invisalign treatment e-card and Essentials Bundle+ for $99.99, receiving a $400 discount off Invisalign treatment with participating providers. The bundle includes an aligner case, cleaning products, and accessories valued at $105.00.
This initiative aims to connect Costco members with Invisalign-trained dental practices, aligning with Align's priority to increase access to their innovative orthodontic solutions. Invisalign has treated over 18 million patients worldwide, including more than 5 million teenagers, offering a comfortable and effective alternative to traditional braces. Studies suggest Invisalign treatment is completed 5 months faster on average than fixed appliances.
Align Technology reported Q2'24 revenues of $1,028.5 million, up 3.1% sequentially and 2.6% YoY. The company achieved a diluted net income per share of $1.28, or $2.41 on a non-GAAP basis. Clear Aligner revenues were $831.7 million, up 1.8% sequentially but down 0.1% YoY, with volumes increasing 6.2% sequentially and 3.2% YoY. Imaging Systems and CAD/CAM Services revenues rose to $196.8 million, a 9.2% sequential and 16.1% YoY increase. Adverse foreign exchange impacts affected revenues and margins. Operating income was $147.0 million with a GAAP operating margin of 14.3% and non-GAAP operating margin of 22.3%. Align also announced a $31.1 million settlement regarding legal matters. Moreover, the company repurchased 0.6 million shares at an average price of $250.73. Looking forward, Align expects Q3'24 revenues between $980M and $1,000M and FY'24 revenue growth of 4%-6% YoY.
Align Technology (NASDAQ: ALGN) has introduced the iTero™ Design Suite, a new software innovation designed to boost practice efficiency and enhance patient experiences. This suite offers doctors an intuitive way to design for in-practice 3D printing of models, bite splints, and restorations, leveraging exocad™ CAD/CAM software.
The iTero Design Suite is now available through an early access program, with full availability expected later this year. It enhances the Align™ Digital Platform, providing seamless end-to-end workflows for dental professionals. The software is compatible with leading 3D printers and aims to shorten time to treatment through simplified design applications.
Operation Smile has announced Align Technology (Nasdaq: ALGN) as the title sponsor of its 2024 International Student Leadership Conference (ISLC). The event, held at Emory University from July 22-28, 2024, aims to develop leadership skills and support patients with cleft conditions globally. Over 300 participants from 20+ countries will attend, thanks to Align's sponsorship.
The conference includes a Day of Caring at the Craniofacial Center at Children's Hospital of Atlanta. Align's EVP of Global HR, Stuart Hockridge, will deliver the keynote speech. This marks Align's fourth time as ISLC title sponsor, reflecting their ongoing partnership with Operation Smile in transforming smiles and changing lives across 37 low- and middle-income countries.
Align Technology (Nasdaq: ALGN) will announce its second-quarter 2024 financial results on July 24, 2024, after market close. The results will be available on the company's Investor Relations website at 4:00 p.m. ET. A conference call to discuss these results will follow at 4:30 p.m. ET, accessible via webcast. Align Technology, known for its Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software, serves over 261 thousand doctors and aims to tap into a 600 million consumer market globally. The company has treated over 17.6 million patients with the Invisalign System to date.
Align Technology announced the award of $300,000 in research grants to universities worldwide as part of their Annual Research Awards Program. Twelve research grants were awarded to institutions in the Americas, Europe, and Asia Pacific. The recipients include prestigious universities like the University of Washington, University of Florida, and Sichuan University. The research covers various topics, including molar distalization, oral microbiome analysis, and the efficacy of probiotics on biofilm around aligners. Dr. Mitra Derakhshan emphasized the importance of these grants in advancing dental research. John Morton noted the high number of applications and the global impact of the research.